{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication, Use of derivatives including swaps, Inverse leveraged exposure, Compounding effect, Short recommended holding period",
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Securities (ETP) aiming to deliver -3x the daily performance of the iShares MSCI Japan ETF, indicating triple leverage and inverse exposure. It uses derivatives integral to its investment strategy, including swaps, to achieve synthetic replication of the index performance rather than physical holding of underlying securities. The product involves significant counterparty and collateral risk inherent in synthetic replication. The daily leverage rebalancing causes a compounding effect, making returns over periods longer than one day diverge from the expected -3x multiple, increasing complexity. The recommended holding period is only one day, reflecting the product's complexity and risk. The product is not capital protected and carries a high risk rating (6/7). The KID explicitly states 'You are about to purchase a product that is not simple and may be difficult to understand,' confirming its complex nature. These features align with MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57 criteria for complex instruments, particularly due to leverage, synthetic replication, embedded derivatives, and inverse exposure. Therefore, the product is classified as complex under MiFID II."
}